Literature DB >> 23598542

Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future.

Veikko Salomaa1, Aki S Havulinna, Heli Koukkunen, Päivi Kärjä-Koskenkari, Arto Pietilä, Juha Mustonen, Matti Ketonen, Aapo Lehtonen, Pirjo Immonen-Räihä, Seppo Lehto, Juhani Airaksinen, Y Antero Kesäniemi.   

Abstract

OBJECTIVE: To examine the incidence, mortality and case fatality of acute coronary syndrome (ACS) in Finland during 1993-2007 and to create forecasts of the absolute numbers of ACS cases in the future, taking into account the aging of the population.
DESIGN: Community surveillance study and modelled forecasts of the future. SETTING AND METHODS: Two sets of population-based coronary event register data from Finland (FINAMI and the National Cardiovascular Disease Register (CVDR)). Bayesian age-period-cohort (APC) modelling. PARTICIPANTS: 24 905 observed ACS events in the FINAMI register and 364 137 in CVDR. MAIN OUTCOME MEASURES: Observed trends of ACS events during 1993-2007, forecasted numbers of ACS cases, and the prevalence of ACS survivors until the year 2050.
RESULTS: In the FINAMI register, the average annual declines in age-standardised incidence of ACS were 1.6% (p<0.001) in men and 1.8% (p<0.001) in women. For 28-day case fatality of incident ACS, the average annual declines were 4.1% (p<0.001) in men and 6.7% (p<0.001) in women. Findings in the country-wide CVDR data were consistent with the FINAMI register. The APC model, based on the CVDR data, suggested that both the absolute numbers of ACS events and the prevalence of ACS survivors reached their peak in Finland around 1990, have declined since then, and very likely will continue to decline until 2050.
CONCLUSIONS: The ACS event rates and absolute numbers of cases have declined steeply in Finland. The declining trends are likely to continue in the future despite the aging of the population.

Entities:  

Keywords:  CORONARY ARTERY DISEASE

Mesh:

Year:  2013        PMID: 23598542     DOI: 10.1136/heartjnl-2012-303216

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Forecast of myocardial infarction incidence, events and prevalence in England to 2035 using a microsimulation model with endogenous disease outcomes.

Authors:  Peter Scarborough; Asha Kaur; Linda J Cobiac
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

2.  Acute Mesenteric Ischemia Is a More Common Cause than Expected of Acute Abdomen in the Elderly.

Authors:  Jussi M Kärkkäinen; Tiina T Lehtimäki; Hannu Manninen; Hannu Paajanen
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

3.  Gender-specific and age-specific differences in unstable angina pectoris admissions: a population-based registry study in Finland.

Authors:  Ville Kytö; Jussi Sipilä; Päivi Rautava
Journal:  BMJ Open       Date:  2015-10-15       Impact factor: 2.692

4.  Likelihood and predictors of ST-elevation in patients hospitalized for myocardial infarction.

Authors:  Ville Kytö; Jussi Sipilä; Päivi Rautava
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

5.  Trends in Cardiovascular Disease Morbidity and Mortality in American Indians Over 25 Years: The Strong Heart Study.

Authors:  Clemma J Muller; Carolyn J Noonan; Richard F MacLehose; Julie A Stoner; Elisa T Lee; Lyle G Best; Darren Calhoun; Stacey E Jolly; Richard B Devereux; Barbara V Howard
Journal:  J Am Heart Assoc       Date:  2019-10-25       Impact factor: 5.501

6.  SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.

Authors: 
Journal:  Eur Heart J       Date:  2021-07-01       Impact factor: 35.855

7.  Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study.

Authors:  Pekka Jousilahti; Tiina Laatikainen; Markku Peltonen; Katja Borodulin; Satu Männistö; Antti Jula; Veikko Salomaa; Kennet Harald; Pekka Puska; Erkki Vartiainen
Journal:  BMJ       Date:  2016-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.